Public Chemotherapy-free ‘cancer vaccine’ moves from mice to human trials at Stanford

https://www.sfgate.com/bayarea/article/Chemotherapy-free-cancer-vaccine-moves-from-12777406.php

A few excerpts from the article:

"A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial."

"The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body's immune system to attack tumors."


"The treatment is not a true vaccine that creates lasting immunity, but it does feature a vaccine-like injection carrying two immune-stimulators that activate the immune system's T cells to eliminate tumors throughout the body."


"Levy, along with Stanford instructor of medicine Idit Sagiv-Barfi, published their study on the cancer-curing effect of immunotherapy on January 31 in Science Translational Medicine. Levy is a pioneer in the field of cancer immunotherapy having contributed to the development of rituximab, one of the first monoclonal antibodies approved for use as an anti-cancer treatment in humans."